Stay updated on SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial

Sign up to get notified when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.1 to 2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T05:17:55.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.1%
    Check dated 2025-01-19T19:43:25.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.
    Difference
    0.2%
    Check dated 2025-01-12T16:54:31.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.1%
    Check dated 2024-12-14T11:52:22.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The results of the Phase II trial on sequential pembrolizumab and radiotherapy for locally advanced NSCLC with high PD-L1 expression have been posted, detailing efficacy and safety outcomes, including progression-free survival and overall survival rates.
    Difference
    39%
    Check dated 2024-12-07T09:37:44.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The website has added new features, while several detailed data fields and options for downloading study information in various formats have been removed.
    Difference
    4%
    Check dated 2024-11-22T18:45:30.000Z thumbnail image

Stay in the know with updates to SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SPRINT: Personalized Radio-Immunotherapy for NSCLC Clinical Trial page.